GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Waters Corp (BSP:WATC34) » Definitions » Total Liabilities

Waters (BSP:WATC34) Total Liabilities : R$17,034 Mil (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Waters Total Liabilities?

Waters's Total Liabilities for the quarter that ended in Dec. 2023 was R$17,034 Mil.

Waters's quarterly Total Liabilities declined from Jun. 2023 (R$18,332.27 Mil) to Sep. 2023 (R$17,738.12 Mil) and declined from Sep. 2023 (R$17,738.12 Mil) to Dec. 2023 (R$17,034.22 Mil).

Waters's annual Total Liabilities declined from Dec. 2021 (R$15,423.05 Mil) to Dec. 2022 (R$14,566.29 Mil) but then increased from Dec. 2022 (R$14,566.29 Mil) to Dec. 2023 (R$17,034.22 Mil).


Waters Total Liabilities Historical Data

The historical data trend for Waters's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waters Total Liabilities Chart

Waters Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11,383.16 13,416.23 15,423.05 14,566.29 17,034.22

Waters Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14,566.29 14,099.67 18,332.27 17,738.12 17,034.22

Waters Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Waters's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3868.784+(11585.278+1347.126
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+233.03)
=17,034

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=22670.659-5636.441
=17,034

Waters's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3868.784+(11585.278+1347.126
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+233.03)
=17,034

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=22670.659-5636.441
=17,034

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Waters Total Liabilities Related Terms

Thank you for viewing the detailed overview of Waters's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Waters (BSP:WATC34) Business Description

Traded in Other Exchanges
Address
34 Maple Street, Milford, MA, USA, 01757
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2022, Waters generated 59% from pharmaceutical customers, 31% from industrial clients, and 10% from academic/government institutions.

Waters (BSP:WATC34) Headlines

No Headlines